Vortex Pharma Solution ApS — Credit Rating and Financial Key Figures
CVR number: 43009672
Hjortevænget 32, 2880 Bagsværd
Income statement (kDKK)
2022 | 2023 | 2024 | |
---|---|---|---|
Fiscal period length | 12 | 12 | 12 |
Net sales | |||
Gross profit | 319.11 | -58.99 | 613.16 |
Costs of management | -73.29 | - 149.42 | - 217.81 |
Costs of distribution | -18.85 | -84.68 | -80.90 |
EBIT | 226.98 | - 293.08 | 314.45 |
Other financial expenses | -1.63 | -2.52 | -2.76 |
Pre-tax profit | 225.35 | - 295.60 | 311.69 |
Income taxes | -52.06 | -9.05 | |
Net earnings | 173.28 | - 295.60 | 302.63 |
Assets (kDKK)
2022 | 2023 | 2024 | |
---|---|---|---|
Intangible assets total | |||
Tangible assets total | |||
Investments total | |||
Long term receivables total | |||
Inventories total | |||
Current trade debtors | 166.80 | 193.84 | |
Current other receivables | 0.01 | ||
Short term receivables total | 166.80 | 193.84 | 0.01 |
Cash and bank deposits | 288.41 | 85.93 | 514.55 |
Cash and cash equivalents | 288.41 | 85.93 | 514.55 |
Balance sheet total (assets) | 455.21 | 279.77 | 514.55 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | |
---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 |
Shares repurchased | 75.00 | ||
Other reserves | 98.28 | - 196.64 | 105.99 |
Retained earnings | - 173.28 | 295.60 | - 302.63 |
Profit of the financial year | 173.28 | - 295.60 | 302.63 |
Shareholders equity total | 213.28 | - 156.64 | 145.99 |
Non-current liabilities total | |||
Current trade creditors | 5.08 | 0.12 | 2.09 |
Current owed to group member | 15.50 | 149.34 | 102.29 |
Other non-interest bearing current liabilities | 221.33 | 286.95 | 264.18 |
Current liabilities total | 241.92 | 436.41 | 368.56 |
Balance sheet total (liabilities) | 455.21 | 279.77 | 514.55 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.